2-AMINOBENZOXAZOLE CARBOXAMIDES AS 5HT3 MODULATORS
申请人:Yang Zhicai
公开号:US20080255114A1
公开(公告)日:2008-10-16
Compounds of formulae I, II and III:
are disclosed as 5-HT3 inhibitors. The compounds are useful in treating CINV, IBS-D and other diseases and conditions.
The present invention provides a quinazoline derivative represented by the following formula (I):
wherein R
1
and R
2
represent a hydrogen atom, a halogen atom, or a lower alkyl group optionally having a substituent; Z represents a cycloalkyl group having a substituent or a cycloalkenyl group having a substituent; and Q represents a bicyclic heteroaryl group optionally having a substituent, or a pharmaceutically acceptable salt thereof. Since the compound has an inhibitory effect on the Wnt/β-catenin signaling pathway and exhibits an antitumor effect, it is useful as a medicine.
[EN] 2-AMINOBENZOXAZOLE CARBOXAMIDES AS 5HT3 MODULATORS<br/>[FR] 2-AMINOBENZOXAZOLE CARBOXAMIDES EN TANT QUE MODULATEURS DE 5HT3
申请人:AMR TECHNOLOGY INC
公开号:WO2008019372A2
公开(公告)日:2008-02-14
[EN] Compounds of Formulae (I), (II) and (III): are disclosed as 5-HT3 inhibitors. The compounds are useful in treating CINV, IBS-D and other diseases and conditions. [FR] L'invention concerne des composés de formule I, II et III utilisés comme inhibiteurs de 5-HT3. Les composés sont utiles pour traiter des nausées et vomissements provoqués par la chimiothérapie (NVPC), un syndrôme du côlon irritable à prédominance de diarrhée (IBS-D) et d'autres maladies et conditions.